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Abstract 
A series of amphiphilic linear AB, BAB and star shaped (AB)3 block copolymers of PCL/P(M)AA 
have been used for preparation of nanoparticles and drug entrapment. Both the topology of the 
copolymer and the type of hydrophilic segment are much influencing the critical aggregation 
concentration (CAC). Two different model drugs, i.e. indomethacin and quercetin, have been 
employed to investigate drug-copolymer interactions. The size of nanoparticles determined by 
DLS is less than 160 nm and increases with the amount of drug entrapped in their hydrophobic 
interior. Drug loading experiments with the nanoparticles based on PAA block copolymers 
demonstrate a higher efficiency for the star structure, whereas the PMAA star copolymer presents 
the lowest entrapment ability. The release properties of polymeric self-assemblies being potential 
candidates for new nanocarriers in drug delivery systems have been studied at room temperature 
and 37 C in phosphate buffer solutions with pH equal to 5 and 7.4. The kinetic profiles show a 
strong relation to the copolymer’s topology, indicating the lowest release rates from the star based 
superstructures, while the PMAA particles are less stable than those containing PAA segment(s). 
The drug release could be controlled by changing the pH value, whereas the influence of 
temperature is minor.  
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Introduction 
 In recent years, the development of amphiphilic copolymers that self-assemble in aqueous 
solution has attracted much attention
[1,2]
 due to the wide range of potential applications, especially 
as carriers in drug delivery systems (DDS). They form micelles with core-shell nanostructures, 
which after loading with poorly water soluble drugs, can be introduced into the human body and 
delivered to specific organ or target site, where the drug is expected to be released in a controlled 
manner. In this way, accumulation of drug is avoided leading to a reduction of toxic side effects, 
what is especially important in the case of application of anticancer drugs with nonspecific 
toxicity to normal cells.
[3-7]
 Polymeric superstructures are characterized with a lower critical 
aggregation concentration (CAC) than micelles formed from low molecular weight surfactants, 
what is related to better stability and slower dissociation to free polymer chains.
[5,8]
 One of the 
major issues in drug delivery systems is to achieve a long blood circulation half-life, which can be 
regulated by a particle size smaller than 200 nm. Indeed, if the micelles are recognized as foreign 
colloidal particles, they will be immediately removed from blood circulation through phagocytosis 
by the cells of the reticuloendothelial system (RES).
[5,9,10]
 
The amphiphilic copolymers based on aliphatic biodegradable polyesters, such as poly( -
caprolactone) (PCL) with high permeability to many drugs, can be employed as micellar carriers 
for controlled drug release.
[3,4,11-14]
 The studies on micellization of PCL copolymers with 
hydrophilic segments of poly(ethylene oxide),
[5,7,15-17]
 and poly(dimethylamino)ethyl methacrylate 
[6,18]
 are widely reported in literature. It was shown that the variation of the copolymer’s 
composition provided an opportunity to modify thermodynamic and kinetic stability, 
degradability, or release properties of the resulting micelles/aggregates.
[10,19,20]
 In aqueous 
solution, the hydrophobic character of the core enables incorporation of poorly water soluble 
drugs, for example indomethacine (IMC) or quercetin (QUE), into its interior by covalent or non 
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covalent bonding through hydrophobic interactions, making use of experimental methods such as 
dialysis, salting out procedure or the solvent evaporation method.
[19-23]
  
According to the literature data
[24]
 and Human Prescription Drug Label, IMC (2-{1-[(4-
chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid) is a non-steroidal, anti-
inflammatory drug (NSAID) employed in the treatment of arthritis, gout, ankylosing spondylitis, 
bursitis, or tendinitis. This practically insoluble in water compound shows antipyretic and 
analgesic properties and reduces swelling and tenderness. In pharmacology, IMC is often available 
under the brand name Indocin. The second selected drug QUE (2-(3,4-dihydroxyphenyl)-3,5,7-
trihydroxy-4H-1-benzopyran-4-one) is a flavonoid found in fruits and vegetables as well as in 
some seeds.
[25]
 It presents anti-inflammatory and antioxidant properties and is known to have 
protective benefits when it comes to heart disease, while according to the American Cancer 
Society it may be effective in the prevention and treatment of cancer. Some early studies have also 
suggested that QUE may help to control allergies and asthma by preventing the release of 
histamine, which is a substance that irritates the body cells causing sneezing, itching, and other 
allergy type reactions.
[26]
 However, till now QUE has not been evaluated by Food and Drug 
Administration for safety or efficacy. 
In this article we have chosen to focus on amphiphilic linear and 3-armed star shaped block 
copolymers that are able to self-assemble into superstructures with a hydrophobic PCL core 
surrounded by a hydrophilic shell formed from poly(methacrylic acid) or poly(acrylic acid) 
(PMAA or PAA, respectively) with varying degree of polymerization. In this case the 
amphiphilicity was introduced via post-polymerization method allowing for long-term storage of 
copolymers with tert-butyl masking groups, which can be easily removed yielding weak acidic 
groups. Additionally, the hydrophilic P(M)AA forms a negatively charged surface, which may 
enhance the extent of in vitro uptake into various cell lines as well as present potential bioadhesion 
making them promising candidates for drug delivery to mucosal surfaces, such as respiratory, 
gastrointestinal and urogenitary tracts.
[19] 
Generally, it is postulated that amphiphilic star 
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copolymers in comparison with their linear polymeric analogs can be organized into a more stable 
nanoassemblies.
[24]
 Previously, the micelles based on diblock copolymers combining PCL and 
PAA were stabilized by cross-linking PAA shell, and then PCL core was selectively degraded to 
generate nanoscale cage-like membranes.
[27]
 In other case the amphiphilic eight-arm star triblock 
copolymers with PCL-b-PAA-b-PCL arms and resorcinarene core were self-assembled into 
spherical micelles.
[28]
 However, up to now the studies on PCL/P(M)AA micelles used for drug 
loading and release have not been reported. Our current work is aimed to compare the micellar 
characteristics of both drug-free and drug-loaded particles based on linear and star shaped PCL-b-
PMAA and PCL-b-PAA copolymers. The systems were investigated in aqueous environment 
using fluorescence spectrophotometry, dynamic light scattering (DLS) and UV-Vis spectroscopy. 
The effect of temperature on particle size as well as the influence of pH and temperature on in 
vitro release behavior of IMC and QUE drugs from the aggregates is described. The star-shaped 
structure of PCLs with high-molecular weight but relatively short chains, in comparison to linear 
PCLs with similar molecular weight, lead to smaller hydrodynamic radius and lower crystallinity, 
which may affect the properties of polymer-drug system.
[29]
 According to this, the copolymers 
with star structure provide enhanced stability of resulted nanoparticles, which are able to release 
drug at lower rate in the controlled manner. A schematic illustration of the route of research is 
presented in Scheme 1. 
 
Scheme 1 
 
Experimental Part 
Materials. Mono-, di-, and tri-bromoester functionalized poly(ε-caprolactone)s (PCL-Br: Mn = 
3100 g/mol, DPCL = 25; PCL-Br2: Mn = 2950 g/mol, DPCL = 20; PCL-Br3: Mn = 1450 g/mol, DPCL 
= 10) were prepared according to a previously described procedure.
[30]
 Tert-butyl methacrylate 
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(tBMA, Aldrich, 98 %), and tert-butyl acrylate (tBA, Alfa Aesar, 99 %) were dried over molecular 
sieves and stored in a freezer under nitrogen. Copper (I) bromide (CuBr, Fluka, 98 %) and copper 
(I) chloride (CuCl, Fluka, 97 %) were purified as reported in literature.
[30]
 4,4'-Dinonyl-2,2'-
dipyridyl (dNdpy, Aldrich, 97 %), N,N,N’,N’,N’’-pentamethyldiethylenetriamine (PMDETA, 
Aldrich, 99 %), trifluoroacetic acid (TFA, Aldrich, 99 %), indomethacin (IMC, Alfa Aesar, 98 %), 
and quercetin (QUE, Aldrich, 98 %) were used as received. All other chemicals were applied 
without purification. Distilled-deionized water was prepared with a Milli-Q Plus System 
(Millipore). 
 
Synthesis of block copolymers with acidic groups ((PCL-b-PAA)n and (PCL-b-PMAA)n, with n 
equal to 1-3): The detailed procedure of atom transfer radical polymerization (ATRP) of tBA or 
tBMA initiated by mono-, di- and tribromoester-functionalized PCL, which yielded linear di- and 
triblock copolymers as well as three-armed star shape block copolymers, was reported in our 
previous paper.
[30]
 The resulting hydrophobic block copolymers were dissolved in CH2Cl2 (3 ml 
per 0.1g of copolymer), and then trifluoroacetic acid (TFA) (5 fold molar excess relative to the 
tert-butyl groups) was added. The reaction was performed for 24 h at room temperature with 
continuous stirring. The triblock and star-shaped copolymers were already precipitated from the 
reaction mixture, while diblock copolymers were precipitated in diethyl ether or heptane. Then, 
the amphiphilic polymers were dried under vacuum to constant mass.  
 
Nanoparticle formation. Nanoparticles were prepared via dialysis method. The amphiphilic 
copolymer was dissolved in THF/H2O (20:1 vol:vol) after what an equal amount of H2O was 
added dropwise under gentle stirring and the system was stirred overnight to let micelles form. 
The prepared solution was dialyzed against water for 48 h to remove THF and then freeze dried.  
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Incorporation of drug into polymeric nanoparticles. The amphiphilic copolymer and drug 
(IMC, QUE) were dissolved in an organic solvent with the weight ratio of polymer:drug = 1:0.5 
(or 1:1). The drug-loaded self-assemblies were prepared according to the same procedure as drug-
free nanoparticles. After removal of the organic solvent, the aqueous solution was sonicated and 
then centrifuged to remove unloaded drug. The drug-loaded particle suspension was then frozen 
and lyophilized.   
Characterization. 
 1
H NMR spectra were recorded in CDCl3 (Eurisotop) and  DMSO-d6 (Eurisotop) on a 
Bruker Avance 300 at 300 MHz. Diffusion ordered nuclear magnetic resonance spectroscopy 
(DOSY) NMR spectra were recorded in DMSO-d6 (Eurisotop) on a Bruker AM500 spectrometer 
at 500 MHz.  
IR spectra were obtained on a Perkin-Elmer Spectrum 1000 FT-IR Spectrometer using 
Horizontal Attenuated Total Reflection (HATR). 
 Critical aggregation concentration (CAC) of polymeric nanoparticles was measured by 
fluorescence spectrophotometry (Cary Eclipse Fluorescence Spectrophotometer, Varian, Agilent 
Technologies) using pyrene as fluorescence probe. Excitation spectra of pyrene ( em = 390 nm) 
were recorded at polymer concentrations ranging from 5 x 10
-4
 to 1.0 mg/ml and constant 
concentration of pyrene (3.0x10
-4
 M). The CAC values were estimated from the plot of the 
intensity ratio (I336/I332) from pyrene excitation spectra vs. log C (where C is concentration in 
mg/ml) as cross-over point at low polymer concentration.  
 The particle size and its distribution were measured at 25 C and/or 37 C using dynamic 
light scattering (DLS, Zetasizer Nano-ZS, Malvern) equipped with a He-Ne laser at fixed 
scattering angle (173 ). Before measurement the sample (1 mg/ml) was sonicated for 0.5 h and 
filtered through syringe filter (pore size 0,45 m). 
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 The drug loaded particles were dissolved in THF (0.3 – 0.5 mg/ml) and sonicated for 10 
min. The amount of entrapped drug was determined by UV-vis spectrohotometry (Specord 200PC, 
Analytik Jena AG) measuring absorbance at  = 319 nm for IMC or at  = 373 nm for QUE and 
using a proper calibration curve. Drug loading efficiency (DLE, %) and drug entrapment 
efficiency (DEE, %) were calculated from the following equations: 
 
%100
micelles loaded drug ofamount 
micellesin  drug ofamount 
DLE        (1) 
%100
fed drug ofamount 
micellesin  drug ofamount 
DEE         (2) 
 
The release behavior of self-assemblies loaded with IMC or QUE were studied in different 
phosphate buffer solutions (PBS) with varying pH value and at different temperatures with pH 
equal to 7.4. Lyophilized drug-loaded polymeric nanoparticles were dissolved in PBS with pH 7.4 
or 5.0 (5 mg in 2.5 ml). The solution was introduced into a dialysis membrane bag, which was 
placed into a glass cylinder with 50 ml of PBS and stirred at a certain temperature (37 C or room 
temperature). At appropriate time intervals, 2.5 ml of the buffer solution sample was taken from 
the release medium to determine the concentration of released drug by UV-Vis at  = 319 nm or at 
 = 373 nm for IMC or QUE, respectively. Each result is an average of three parallel 
measurements. 
 
Results and discussion 
Amphiphilic block copolymers 
 The hydrophobic block copolymers containing PCL and PtB(M)A segments, with linear or 
star shaped topologies, various molecular weights (Mn,GPC = 8 000 – 40 000 g/mol) and narrow 
molecular weight distributions (Mw/Mn,GPC = 1.15 – 1.29)
[30]
 were converted into amphiphilic ones 
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by acidic hydrolysis with TFA at room temperature. The selective reaction resulted in 
(meth)acrylic acid units (AA and MAA) after removing tert-butyl groups (Scheme 2). Previously, 
these mild conditions of deprotection were employed for the hydrolysis of PtB(M)A combined 
with another poly(meth)acrylate segment or arranged in more complex polymer structures.
[31-33]
  
 
Scheme 2 
 
 The representative HATR-FTIR spectra of triblock copolymer III before and after 
deprotection are shown in Figure 1. In both spectra, the stretching vibrations of the C–O bond are 
recognized as the band at 1100–1245 cm-1, while a narrow strong band around 1700 cm-1 is 
assigned to stretching vibrations of the C=O group. In the 3100-2800 cm
-1
 region characteristic for 
stretching of C–H bonds, peaks originating from (CH2), and (CH3) are observed. After 
hydrolysis, the doublet at 1391 and 1366 cm
-1
 corresponding to the tert-butyl group is 
significantly diminished, whereas a broad band characteristic for O–H stretching in the acidic 
groups of (M)AA units appears in the region 3700–3100 cm-1, which confirms effective 
transformation of tB(M)A units into (M)AA.  
 
Figure 1 
 
 The 
1
H NMR analysis also confirms the selective cleavage of tert-butyl groups without 
changes of ester linkages in PCL units. Indeed, after hydrolysis the signal at 1.45 ppm 
corresponding to tert-butyl protons is not observed, whereas the remaining multiplet signal with 
low intensity at 1.3-1.5 ppm, is assigned to the methylene protons in PCL segments (Figure 2a,
 
Figure S1 in Supporting Information). Additionally, the DOSY NMR was used as a powerful 
method based on different apparent diffusion coefficients of each chemical species in the solution, 
which depend on the molar mass and other hydrodynamic properties (size, shape or charge) as 
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well as physical properties of the surrounding environment, such as viscosity, temperature, etc.
[34]
 
The result is a 2D spectrum with chemical shift on one axis and the distribution of diffusion 
coefficients on the other axis. In the presented DOSY spectrum (Figure 2b) of sample VI, signals 
coming from only one polymer fraction are observed, which confirms that the resulting 
amphiphilic PCL/PMAA block copolymer is formed without any destruction of polymeric chains 
during the removal of tert-butyl groups. 
 
Figure 2  
 
The amphiphilic copolymers with various architectures, linear diblock AB (I, II, V, VI) 
and triblock BAB (III, VII), as well as three-armed star shaped (AB)3 (IV, VIII), and different 
type of hydrophilic block, PMAA (I-IV) or PAA (V-VIII), which are presented in Table 1, were 
used for the micellization process. Additionally, differential degree of polymerization (DPCL vs. 
DP(M)AA), segment/arm length (m(M)AA), and content of hydrophilic segment(s) (Fhydrophil) are 
expected to be responsible for the self-assembly properties of polymers in aqueous solution.  
 
Table 1  
 
Nanoparticle properties and drug loading  
 In aqueous solutions, a wide range of superstructures can be obtained through self-
assembling amphiphilic block copolymers, most commonly into spherical micelles, cylindrical 
micelles, and vesicles,
[35]
 whereas the micelle-like aggregates were postulated in the case of 
amphiphilic star block copolymers PMMA-b-PAA with low number of arms (f = 4)
[36]
. The 
properties of self-assemblies prepared from linear and star-shaped block copolymers PCL-b-
P(M)AA were characterized by critical aggregation concentration (CAC) and particle size, while 
drug loading efficiency (DLE) and drug entrapment efficiency (DEE) were studied using drug-
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loaded nanoparticles. Two different biologically active substances, IMC and QUE, were chosen as 
model drugs. IMC was loaded into all prepared nanoparticles, while QUE was only used in 
selected ones for comparative purposes.  
The CAC parameter, as a minimal concentration above which both self-assembled 
structures and single polymer chains are present in solution, confirms aggregation but also gives 
information about stability of resulted nanostructures. In drug delivery application, it is important 
to avoid a decrease of the polymer concentration below CAC after application into the human 
body, because this would lead to different side effects connected with the release of high amounts 
of drugs unless the micelles/aggregates are kinetically stable enough.
 
The rate of disassembly 
depends on the physical state of the core, which is affected by size, thermal stability and the 
presence of crystalline domains in the core.
[19] 
The CAC values were measured using fluorescence 
spectrophotometry, where a strongly hydrophobic pyrene, known for exhibiting photochemical 
properties and its remarkably long life-time, was employed as a fluorescence probe. In the inset of 
Figure 3, typical fluorescence excitation spectra of pyrene in aqueous solution for copolymer III 
are presented. The spectra were recorded from 280 to 380 nm at fixed pyrene concentration for 
varying concentrations of amphiphilic copolymer. This shows no micelles can entrap the probe 
below CAC, thus the fluorescence intensity is almost non-detectable because of very low 
solubility of pyrene in water (2-3 M). The maximum of the right peak is shifted from 338 to 333 
nm with the decrease in polymer concentration and the intensity of fluorescence also decreases as 
a result of smaller amount of solubilized pyrene.  
 
Figure 3 
 
 The plot of the intensity ratio I338/I333 vs. logarithm of polymer concentration (logC) 
(Figure 3) for copolymer III was prepared on the basis of pyrene excitation spectra (at a constant 
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em = 390 nm). The CAC values for all copolymers were determined as a cross point of tangents to 
the curve and are collected in Table 2. As expected, the hydrophobicity/hydrophilicity ratio is one 
of the major factors, which influence CAC. According to the literature, a higher hydrophobicity 
results in lower CAC values
[37,38]
, what can be observed in both groups of investigated 
copolymers. The worth noting exception is that the CAC for sample III is unexpectedly lower 
than that of II, but this can be explained by significantly longer PMAA segments probably leading 
to a higher Tg, which in fact results in improved superstructure stability.
[19]
 For copolymers with 
the same length of the hydrophobic block, the increase in the polymerization degree of 
poly(meth)acrylic segment(s) leads to higher CAC values and lower aggregation number of the 
polymeric chains. This effect can be observed when comparing copolymers I and II. Their 
hydrophilic fraction, which is strongly related to the polymerization degree of PMAA segment, for 
I (Fhydrophil. = 74 mol% at DPMAA = 70) is lower than in II (Fhydrophil. = 78 mol% at DPMAA = 89) 
yielding much lower CAC (0.009 vs. 0.018 mg/ml, respectively). A similar behavior is noticed for 
the pair of AB copolymers V and VI with polyacrylic segments (CAC = 0.006 mg/ml at Fhydrophob. 
= 60 mol% vs 0.009 mg/ml at 81 mol%, respectively). The stability of micelles may also depend 
on copolymer structure in relation to topology and type of hydrophilic segment, i.e. 
polymethacrylic vs polyacrylic. The CAC values for linear diblock copolymers containing PAA 
are lower than for their analogs with PMAA (e.g. 0.009 mg/ml for VI < 0.018 mg/ml for II), 
whereas for 3-armed star shaped copolymers the correlation is exactly reversible (0.122 mg/ml for 
VIII > 0.067 mg/ml for IV). In the case of linear triblock copolymers, independently on the type 
of hydrophilic segment, the CAC values are similar (0.013 for VII  0.012 for III mg/ml), but 
those copolymers also differ in the length of hydrophilic chains. Additionally, the CAC can be 
also controlled by the copolymer’s topology, and the values are adjustable in a wide range from 
0.006-0.018 mg/ml for linear chains to 0.067-0.122 mg/ml for star-shape structures. The highest 
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CACs presented by both PMAA and PAA star copolymers can be explained by hydrophobic 
interactions between star cores. 
Hydrophobic drugs such as IMC or QUE, which can not be directly introduced into the 
human body due to their low solubility in aqueous environment (solubility of IMC in water is 
0.937 mg/l, while of QUE it is 60 mg/l 
[39]
), can be delivered by polymeric nanocarriers capable of 
releasing drugs in a controlled way. The drugs were loaded into the interior of the micelle 
according to the same procedures as those used for the preparation of drug free nanoparticles. At 
this stage, an important factor is the selection of the solvent that shows the ability to dissolve both 
drug and amphiphilic polymer. The amount of loaded drug was determined using UV-Vis 
spectroscopy by measuring the absorbance of IMC or QUE (at  = 319 or 373 nm, respectively) 
and applying previously prepared calibration curves. The evaluated parameters of the amount of 
drug incorporated into the micelle (Drug Loading Efficiency, DLE) and the percentage of fed drug 
(Drug entrapment efficiency, DEE) are collected in Table 2. The ability of drug entrapment is 
adjusted by properties of copolymer (nature and length of core forming segments, nature of shell-
domain, total molecular weight of polymer, etc.), and drug (nature, molecular volume, 
concentration), as well as drug-copolymer interaction.
[19,26]
 Among the group of block copolymers 
containing PMAA, the values of DLE for IMC are in the range of 9 to 57 % and are increasing as 
follows: IV < II < III < I. Smaller values of CAC result in higher number of polymer chains to be 
present in the form of micelles and, as an effect, the degree of drug solubilization increases due to 
the larger hydrophobic volume availability for drug entrapment. In the group of PCL-b-PAA 
copolymers, DLE of IMC is much lower and does not present the above tendency, but this may be 
caused by the differences in the character of hydrophilic segments (PAA vs PMAA). However, the 
increase in hydrophilicity of copolymers with the same topology leading to higher CAC values (I 
vs. II and IV vs. V) results in the fact that smaller amounts of drug can be entrapped in the core 
(DLE = 56.8 % vs. 18.8 % or 13.4 % vs. 10.0 %, respectively). The influence of drug nature on 
the DLE value is evaluated by comparison of the IMC loaded micelles with that one’s containing 
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QUE. The results show better compatibility of IMC than QUE to the investigated copolymers, 
yielding higher values of DLE (9.3 % vs. 3.7 % for IV or 15.4 % vs. 9.7 % for VIII, respectively). 
The amount of loaded drug also depends on the initial weight ratio of polymer to drug 
(polymer:drug = 1:0.5 or 1:1) (Figure 4). In the case of QUE-loaded samples, DLE is higher for 
nanoparticles prepared with the lower weight ratio equal to 1:0.5 instead of 1:1 (3.7 % vs. 3.2 % 
for IV or 9.7  vs. 6.9 % for VIII, respectively), while for IMC-loaded micelles the opposite 
relationship is observed (VIII: DLE = 15.4 % for polymer:drug = 1:0.5 vs. 20.0 % for 1:1). It is 
supposed that in the first example, when polymer:drug ratio exceed 1:0.5, the aggregation of 
unloaded QUE occurs during the micelles preparation leading to lower DLE values. This is a 
result of stronger hydrophobic interaction between drug molecules than that between drug and 
copolymer as the amount of QUE increased. Previously, similar tendency was discovered e.g. for 
the loading of Taxol into nanospheres composed of methoxy poly(ethylene glycol) and PCL block 
copolymer, where DLE increased from 4 % to 21 % as polymer:drug ratio was raised from 1:0.05 
to 1:0.5 and then suddenly dropped to 9 % for polymer:drug ratio equal to 1:1.
[7]
 
 
Table 2  
 
Figure 4 
 
The sizes of nanoparticles before and after drug loading were determined by DLS at 25 and 
37 C (Table 3). This parameter is responsible for particle circulation in the organism, mechanism 
of the entry into cells and, in turn, the kinetics and extent of cell uptake. The formed polymeric 
self-assemblies are characterized by monomodal size distributions by intensity, which is shown 
for sample VI in Figure 5. It can be observed that there are no significant changes in particle 
hydrodynamic diameter (dh), indicating slightly smaller micelles at higher temperature for most of 
the samples when temperature is raised from 25 to 37 C, The other observation shows that when 
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the length of hydrophilic segment(s) was increased (I vs. II and V vs. VI), which was related to 
higher CAC values, a larger nanoparticles were obtained (66.1 vs. 89.8 nm and 49.7 vs. 153.4 nm, 
respectively). The entrapment of drug inside the core results in the increase of hydrodynamic 
diameter, with the exception of sample VI, where smaller size of loaded nanoparticles may be 
explained by reduction of hydrophilic/hydrophobic repulsion of PCL, leading to the contraction of 
the core.
[20]
 The polymer:drug initial weight ratio also influences the particle size, which in the 
case of IMC-loaded VIII is correlated to the formation of larger particles at higher ratio, but for 
QUE-loaded IV opposite interaction of polymer-drug is indicated due to different nature of drug. 
Polydispersity indices (PDI) measured by DLS for unloaded nanoparticles are in the range of 
0.133 – 0.612 suggesting widely differential participation of extra associations between micelles, 
while drug-loaded self-assemblies are characterized with narrower size distributions up to 0.548 in 
case of IMC and 0.263 for the selected particles loaded with QUE.  
 
Figure 5 
 
Table 3 
 
Drug release studies  
The release properties were investigated using UV-Vis spectroscopy. Samples of drug 
loaded nanoparticles were dissolved in phosphate buffer solution (PBS) and introduced into a 
membrane dialysis bag. The influence of environment on the release behavior was studied in 
experiments performed in PBS with pH = 7.4 at room temperature and pH = 5 or 7.4 at 37 C. 
These studies are particularly important due to varying pH values in different parts of the human 
body: stomach pH is 1 - 2, in the lower part of small intestine the pH is 7.5  0.4, in ascending 
colon it is around 6.4  0.6, while in gastrointestinal fluid it drops to 4.8.
[6]
 The percentages of 
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released drug from the prepared polymeric micelles were calculated with the respect to the loading 
efficiencies (Table 4).  
 
Table 4  
 
The strong dependencies of drug release on topology and composition, especially within 
10 h, are shown in Figure 6a giving the following relationships for IMC-loaded micelles based on 
PCL/PMAA III (BAB) > II (AB) > IV (AB)3, and PCL/PAA VII (BAB) ~ V (AB) > VI (AB) >  
VIII (AB)3. The highest rate of IMC release at pH = 7.4 and 37 C is observed for the linear 
triblock copolymer with BAB structure (III), which is a reverse behavior compared to star shaped 
copolymer (AB)3, indicating better control of drug release from micelles based on the latter one. 
Additionally, a higher ratio of polymer:drug causes slower release of IMC (VIII vs. VIIIA). 
Figure 6b presents the dependence of drug release rate at different pH values, where the shape of 
curves differs at the first stage of release (up to 10 h), but at longer time the maximum amounts of 
released drugs reach comparable values over 80 %. At pH = 5 the initial release of both IMC and 
QUE is rapid, even suggesting the occurrence of a burst effect that may be a result of the release 
of drug that, instead of being entrapped in the interior of hydrophobic core, is rather located in the 
outer hydrophilic shell or at the interface of those phases, whereas the release at pH = 7.4 is more 
linear and gradually increases. Moreover, the studies performed at different temperatures indicate 
that for copolymers with PMAA the release rate and the maximum amount of released drug is 
higher at 37 C (Figure 6c). In the case of copolymers with PAA (Figure 6d) at room temperature 
the drug is initially released faster, but then the amount of released drug does not further increase, 
while at 37 C the drug is continuously released up to 82.3 – 99.9 %. This behavior shows the 
strong influence of the type of hydrophilic segment, including slower release rate exhibited by 
PAA micelles in comparison to PMAA ones. All these results let us conclude that these micellar 
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systems can be well-fitted to the proper drug in order to deliver it successfully to the expected 
target. 
Different drug release kinetic models (zero order, first order, and Higuchi) were used to 
describe the dissolution profiles, which are evaluated depending on the derived model 
parameters.
[40-43]
 In almost all cases, the release behavior depends on the drug concentration, 
which means that the plots in Figure 6 and Figure 7a do not follow zero-order kinetics 
(cumulative amount of drug released vs. time). However, a linear semilogarithmic plot of 
percentage of drug remaining inside the micelle vs. time in Figure 7b, shows good agreement 
with the first-order equation, yielding a correlation coefficient R
2 
in the range of 0.85 – 0.99. The 
other interpretation of kinetics release, given by the plot of the cumulative amount of released 
drug against the square root of time (Figure 7c), is also in accordance with the Higuchi equation 
(R
2
 = 0.91 – 0.99) that describes the systems in which the release rate is related to drug diffusion. 
According to the experimental data, the release process is diffusion-controlled with small 
deviations from linearity in Figure 7c, which suggest that other factors, probably such as 
fragmentation of PCL segment(s), may influence the drug release behavior. 
 
Figure 6  
 
Figure 7  
 
Conclusions 
 Linear AB and BAB as well as star-shaped (AB)3 hydrophobic block copolymers, 
containing PCL and PtB(M)A segments, were successfully modified into amphiphilic ones by 
hydrolysis of tert-butyl groups in mild condition with TFA at room temperature. The comparison 
of PMAA vs PAA block copolymers indicated that the latter ones self-assemble at lower CAC for 
18 
 
AB copolymers, similar for BAB, and higher values in case of AB3 stars. The resulting micellar 
structures in aqueous solutions show good stability and ability to solubilize poorly water soluble 
drugs such as indomethacin or quercetin. The size of the investigated nanoparticles is below 160 
nm and increases with the amount of loaded drug. The studies confirm that the drug loading 
efficiency and release behavior can be regulated by both the composition and the topology of the 
block copolymers. The lowest ability to entrap the drug is observed for the micelles formed by the 
star-shaped copolymer with PMAA segments (9 %), whereas in the series of PAA block 
copolymers, the star structure is the most efficient (15 – 20 %). The nanoparticles based on AB3 
star polymers exhibit slower drug release than their linear block analogs (45 % vs. 60 – 90 % with 
PMAA and 25 % vs. 55 – 60 % with PAA within 10 hours), and PAA-based block copolymers are 
more efficient for the controlled release of drugs than those with PMAA segments. The release 
experiments at 37 C and room temperature show comparable kinetic profiles, whereas drug 
release rates are significantly reduced in aqueous solutions with pH 7.4. The dependence of the 
release behavior on the drug concentration follows first-order kinetics . The presence of PCL 
segment(s) ensures the biodegradability and biocompatibility of the resulting self-assemblies, 
while P(M)AA segments are expected to influence the bioadhesion of particles suggesting their 
effectiveness as oral or aerosol micellar systems
[19]
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Scheme 1. Schematic illustration of self-assembly of amphiphilic block copolymers.  
 
 
Scheme 2. Transformation of hydrophobic to amphiphilic block copolymers based on PCL. 
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Figures 
 
 
Figure 1. HATR-FTIR spectra of triblock copolymer III before and after deprotection of acidic 
groups. 
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Figure 2. 
1
H NMR (a) and Contour Plot DOSY 
1
H NMR spectrum (b) of AB block copolymer 
(VI) in DMSO-d6. 
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Figure 3. Plot of the intensity ratio I338/I333 from pyrene excitation spectra (at em = 390 nm) vs. 
nanoparticle concentration (logC) for BAB copolymer (III). The inset shows the excitation spectra 
of pyrene at a constant em = 390 nm as a function of copolymer concentration (5 x 10
-4
 – 1 
mg/ml). 
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Figure 4. Effect of weight ratio of amphiphilic copolymer to drug on drug loading efficiency of 
polymeric nanoparticles. 
 
 
Figure 5. Size distribution profiles (by intensity) of nanoparticles based on AB3 copolymer (IV) 
by DLS measurements in aqueous solutions of a) drug-free at 25 C, b) drug-free at 37 C, and c) 
IMC-loaded at 37 C. 
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Figure 6. Drug release profiles from IMC-loaded nanoparticles based on copolymers with 
different topologies (pH = 7.4 at 37 C) (a), (AB)3 based particles at different pH (37 C) (b), 
PCL/PMAA based particles (c), and PCL/PAA particles (d) at different temperature (pH = 7.4). 
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Figure 7. The kinetics of drug release in PBS with pH = 7.4 at 37 C from nanoparticles loaded 
with IMC and QUE a) zero-order plot of percentage of drug released in time, b) a linear plot of log 
(% remaining drug) vs. time for the release data accordance with the first-order equation, and c) a 
linear plot of % of released drug vs. square root of time for the release data in accordance with the 
Higuchi square root model. 
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Tables  
 
Table 1. Properties of the amphiphilic block copolymers used for micellization. 
No 
Polymer 
structure
a)
 
 
DPCL DP(M)AA m(M)AA
b)
 
Fhydrophil.  
[mol%]  
PCL-b-PMAA 
I AB  25 70 70 74 
II AB  25 89 89 78 
III BAB  20 257 128 93 
IV (AB)3  10 181 60 95 
PCL-b-PAA 
V AB  25 38 38 60 
VI AB  25 107 107 81 
VII BAB  20 162 81 89 
VIII (AB)3  10 208 69 95 
a)
 A = PCL; DPCL = 25 for copolymers with AB structure, DPCL = 20 for BAB copolymers, DPCL 
= 10 for (AB)3 copolymers; 
b)
 number of units in one poly(meth)acrylic block 
 
 
Table 2. CAC, drug loading and drug entrapment efficiencies for polymeric nanoparticles.  
No 
CAC  
[mg/ml] 
IMC QUE 
DLE [%] DEE [%] DLE [%] DEE [%] 
I 0.009 56.8 76.7 - - 
II 0.018 18.8 24.2 - - 
III 0.012 29.2 21.4 - - 
IV 
0.067 
9.3 12.8 3.7 5.1 
IVA - - 3.2 2.1 
V 0.006 13.4 11.5 - - 
VI 0.009 10.0 9.0 - - 
VII 0.013 17.2 22.6 - - 
VIII 
0.122 
15.4 17.1 9.7 16.3 
VIIIA 20.0 10.4 6.9 7.2 
polymer:drug = 1:0.5 with exception of IVA and VIIIA (1:1), dash “-“ means not determined. 
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Table 3. Drug-free and drug-loaded particle’s sizes.  
No 
Mean particle size at 25 C [nm] Mean particle size at 37 C [nm] 
Drug 
free 
PDI 
IMC 
load. 
PDI 
QUE 
load. 
PDI 
Drug 
free 
PDI 
IMC 
load. 
PDI 
QUE 
load. 
PDI 
I 66 0.488 81 0.459 - - 63 0.477 - - - - 
II 90 0.374 155 0.462 - - 88 0.425 - - - - 
III 74 0.470 - - - - 69 0.508 - - - - 
IV 
118 0.573 
235 0.131 201 0.243 
105 0.601 
242 0.178 206 0.263 
IVA - - 161 0.235 - - 162 0.251 
V 50 0.133 175 0.472 - - 53 0.250 172 0.548 - - 
VI 153 0.235 71 0.251 - - 147 0.260 72 0.260 - - 
VII 115 0.429 224 0.227 - - 124 0.480 205 0.236 - - 
VIII 
120 0.459 
233 0.231 231 0.132 
133 0.612 
226 0.217 231 0.133 
VIIIA 245 0.266 - - 236 0.292 - - 
polymer:drug = 1:0.5 with exception of IVA and VIIIA (1:1), dash “-“ means not determined. 
 
Table 4. The percentage of drug released at different pH and temperature. 
No 
IMC release [%]  QUE release [%] 
pH = 5 pH = 7.4  pH = 7.4  
 
pH = 5 pH = 7.4  pH = 7.4  
37 C rt 37 C rt 
I - 28.5 -  - - - 
II - 58.6 -  - - - 
III - 96.3 -  - - 86.2 
IV - 95.7 43.2  - 94.3 - 
IVA - - -  86.9 90.6 13.1 
V 93.5 99.9 78.1  - - - 
VI - 89.3 -  - - - 
VII - 99.6 79.7  - - - 
VIII 99.9 82.3 44.7  - 77.5 - 
VIIIA - 53.1 -  95.8 98.5 - 
polymer:drug = 1:0.5 with exception of IVA and VIIIA (1:1), rt – room temperature, dash “-“ 
means not determined. 
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K. Bury, F. Du Prez, D. Neugebauer*  
 
Self-assembling linear and star shaped poly( -caprolactone)/poly[(meth)acrylic acid] block 
copolymers as carriers of indomethacin and quercetin 
 
An investigation of nanoparticles prepared from linear AB, BAB and star-shaped (AB)3 
block copolymers based on poly( -caprolactone) and poly(meth)acrylic acid is performed to 
determine the influence of the polymer’s topology and composition on the drug loading and 
release properties. The self-assemblies have been tested as nanocarriers of indomethacin and 
quercetin, which can be applied in controlled delivery systems. 
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